Intellectual Property,
Health Care & Hospital Law
Aug. 30, 2022
Moderna fires first shot in COVID vaccine patent wars
Moderna explains this apparent about-face by pointing out that it refrained from asserting its patents earlier so as not to interfere with and distract from efforts to bring the pandemic to an end as quickly as possible.
Dariush Adli
President
ADLI Law Group
444 S Flower St
Los Angeles , CA 90071
Email: adli@adlilaw.com
Univ of Michigan Law Sch; Ann Arbor MI
On Aug. 24, Moderna filed two lawsuits against competitors Pfizer and BioNTech, alleging infringement of three of its patents on the mRNA COVID-19 vaccine. The lawsuits were filed in the U.S. Federal District Court in Massachusetts and in Germany, where BioNTech is located, and seek damages for past infringement and future royalty for Pfizer/BioNTech’s alleged unauthorized and unlicensed use of Moderna’s patented COVID-19 vaccine technology. Both Pfizer and BioNTech h...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In